1325147-08-7

Upstream product

• 1325147-07-6 2,3,4-tri-O-benzyl-6-O-(2,3,4,6-tetra-O-benzyl-α-D-galactopyranosyl)-D-glucitol 
• 3282-30-2 pivaloyl chloride 

Downstream Products

• 1325147-09-8 (2S,3S,4R,5S)-5-azido-2,3,4-tris(benzyloxy)-6-((2S,3R,4S,5S,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran-2-yloxy)hexyl pivalate 
• 1325147-10-1 (2S,3S,4R,5S)-5-azido-2,3,4-tris(benzyloxy)-6-((2S,3R,4S,5S,6R)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran-2-yloxy)hexan-1-ol 
• 1325147-11-2 (2S,3R,4S,5S,6R)-2-((2S,3R,4S,5S)-2-azido-3,4,5-tris(benzyloxy)-6-(dodecyloxy)hexyloxy)-3,4,5-tris(benzyloxy)-6-(benzyloxymethyl)tetrahydro-2H-pyran 

Relevant academic research and scientific papers

The total synthesis of immunostimulant α-galactosylceramides from naturally configured α-galactoside raffinose

The total synthesis of absolute anomeric confirmation α- galactosylceramide analogues from raffinose is described. Using the naturally occurring α-galactoside raffinose as the starting material, the easily maneuverable protocol without glycosylation react